Advertisement

Pulmonary Aspergillosis with Presenting Symptom of Hemoptysis

  • Shi-Ping Wu
  • Ling-Wei Wang
Chapter

Abstract

Hemoptysis is one of the most common respiratory symptoms. The main cause of hemoptysis had been previously believed to be pulmonary tuberculosis, bronchiectasis, and lung carcinoma. During recent years, due to improved technology and increasing knowledge of the clinicians about pulmonary aspergillosis, hemoptysis has been increasingly reported to be caused by pulmonary aspergillosis. Actually, hemoptysis is the most common symptom of pulmonary aspergillosis, with an incidence rate of up to 80% and an incidence rate of life-threatening major hemoptysis of about 30%. Pulmonary aspergilloses that most commonly induce hemoptysis include pulmonary aspergilloma and chronic cavitary pulmonary aspergillosis, followed by invasive pulmonary aspergillosis. Strictly speaking, aspergilloma is a radiological diagnosis, which is characterized by nodular or spherical opacity with moderate intensity in irregular cavity with unsmooth inner wall. Singular aspergilloma (SA) can be categorized into chronic pulmonary aspergillosis, referring to parasitic singular aspergillosis with slight or no clinical symptoms and no dynamic radiological changes during at least 3 months observation.

References

  1. 1.
    Schweer KE, Bangard C, Hekmat K. Chronic pulmonary aspergillosis. Mycoses. 2014;57(5):257–70.PubMedCrossRefGoogle Scholar
  2. 2.
    Zhuo S, Luo B. Diagnosis and treatment of pulmonary aspergillosis. Chin J Mod Med. 1998;8(7):31–4.Google Scholar
  3. 3.
    Ba PS, Ndiaye A, Diatta S. Results of surgical treatment for pulmonary aspergilloma. Med Sante Trop. 2015;25(1):92–6.PubMedGoogle Scholar
  4. 4.
    Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:327–60.PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Khana MA, Dara AM, Kawoosa NU, et al. Clinical profile and surgical outcome for pulmonary aspergilloma: nine year retrospective observational study in a tertiary care hospital. Int J Surg. 2011;9(3):267–71.CrossRefGoogle Scholar
  6. 6.
    Ruan J, Zhang T, Duan Y, et al. Surgical treatment of pulmonary tuberculosis complicated by pulmonary aspergilloma. Chin J Med. 2013;93(25):1975–7.Google Scholar
  7. 7.
    Chambon C, Costa JM, Chaumete MT, et al. Galactomannan and polymerase chain reaction for the diagnosis of primary digestive aspergillosis in a patient with acute myeloid leukaemia. J Infect. 2011;43(3):213–4.CrossRefGoogle Scholar
  8. 8.
    Limper AH, Knox KS, Sarosi CA, et al. An official American thoracic society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011;183(1):96–128.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Takahashi-Nakaguchi A, Muraosa Y, Hagiwara D, et al. Genome sequence comparison of Aspergillus fumigatus strains isolated from patients with pulmonary aspergilloma and chronic necrotizing pulmonary aspergillosis. Med Mycol. 2015;53(4):353–60.PubMedCrossRefGoogle Scholar
  10. 10.
    Thompson GR 3rd, Patterson TF. Pulmonary aspergillosis: recent advances. Semin Respir Crip Care Med. 2011;32(6):673–81.CrossRefGoogle Scholar
  11. 11.
    Denning DW, Pleuvry A, Cole DC. Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis. Bull World Health Organ. 2011;89(2):864–72.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Huang Y, Li J, Yue T. CT diagnosis and differential diagnosis of different types of pulmonary aspergillosis. J Med Imaging. 2014;24(4):645–7.Google Scholar
  13. 13.
    Wu Z, Xu Y, Zhang X, et al. Surgical treatment for pulmonary aspergillosis: experience of 36 cases. J Pract Med. 2011;27(2):283–4.Google Scholar
  14. 14.
    Zhang C, Sun C, Cui J. Surgical treatment for 31 cases of pulmonary aspergillosis. Chin J Nosocomial Infect. 2013;23(1):89–90.Google Scholar
  15. 15.
    Zhu J. Diagnosis and treatment of pulmonary aspergilloma: analysis of 28 cases. J Pract Clin Med. 2009;13(5):109–10.Google Scholar
  16. 16.
    Feng C, Lin H, Guo L. Pulmonary aspergillosis: clinical analysis of 17 cases. Chin J Nosocomial Infect. 2006;16(10):1119–21.Google Scholar
  17. 17.
    Zeng D, Wu E, Xue X. Multi layer spiral CT diagnosis of pulmonary aspergillosis. Chin J Med Imaging. 2009;17(5):364–7.Google Scholar
  18. 18.
    Wang Y, Jiang Z, Chan F. CT scan demonstrations of pulmonary aspergillosis. J Huaihai Med. 2011;29(6):478–80.Google Scholar
  19. 19.
    Schulte T, Welcker K, Schatz J, et al. Surgical treatment of pulmonary aspergilloma. Mycoses. 2005;48(Suppl 1):46–50.PubMedCrossRefGoogle Scholar
  20. 20.
    Massard G. Role of surgery in the treatment of pulmonary aspergillosis. Rev Mal Respir. 2005;22(3):466–72.PubMedCrossRefGoogle Scholar
  21. 21.
    Cheng X, Liu J, He J, et al. Non-invasive surgery for pulmonary aspergillosis. Chin J Mod Med. 2003;13(24):81–2.Google Scholar
  22. 22.
    Yu X. Etiological analysis of hemoptysis and its therapeutic development. J Asian Pac Tradit Med. 2008;4(8):63–5.Google Scholar
  23. 23.
    Benjelloun H, Zaghba N, Yassine N, et al. Chronic pulmonary aspergillosis: a frequent and potentially severe disease. Med Mal Infect. 2015;45(4):128–32.PubMedCrossRefGoogle Scholar
  24. 24.
    Hedayati MT, Azimi Y, Droudinia A, et al. Prevalence of chronic pulmonary aspergillosis in patients with tuberculosis from Iran. Eur J Clin Microbiol Infect Dis. 2015;34(9):1759–65.PubMedCrossRefGoogle Scholar
  25. 25.
    Kosmidis C, Denning DW. The clinical spectrum of pulmonary aspergillosis. Thorax. 2015;70(3):270–7.CrossRefPubMedGoogle Scholar
  26. 26.
    Karen CP, Mary ES. Diagnosis and treatment of pulmonary aspergillosis syndromes. Chest. 2014;146(5):1358–68.CrossRefGoogle Scholar
  27. 27.
    Godet C, Philippe B, Laurent F, et al. Chronic pulmonary aspergillosis: an update on diagnosis and treatment. Respiration. 2014;88(2):162–74.CrossRefPubMedGoogle Scholar
  28. 28.
    Liu Y, She D, Sun T, et al. Multicentered retrospective survey of clinically defined pulmonary mycosis during 1998 and 2007 in China. Chin J Tuberc Respir. 2012;34(02):86–90.Google Scholar
  29. 29.
    Patterson KC, Strek ME. Diagnosis and treatment of pulmonary aspergillosis syndromes. Chest. 2014;146(5):1358–68.CrossRefPubMedGoogle Scholar
  30. 30.
    Garnacho-Montero J, Olaechea P, Alvarez-Lerma F, et al. Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient. Rev Esp Quimioter. 2013;26(2):173–88.PubMedGoogle Scholar
  31. 31.
    Kim SH, Kim MY, Hong SI, et al. Invasive pulmonary aspergillosis-mimicking tuberculosis. Clin Infect Dis. 2015;61(1):9–11.PubMedCrossRefGoogle Scholar
  32. 32.
    Kim SH, Kim MY, Hong SI. Pulmonary aspergillosis. Thorax. 2015;70(3):270–7.CrossRefGoogle Scholar
  33. 33.
    Choo JY, Lee KY, Kim MY, et al. Pulmonary tuberculosis confirmed by percutaneous transthoracic needle biopsy: analysis of CT findings and review of correlations with underlying lung disease. Balkan Med J. 2014;31(3):208–13.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Jiang L, Liu X, Zhang X, et al. Misdiagnosis of pulmonary aspergillosis: an analysis of 22 cases. Electron Chin J Diagn. 2015;3(3):208–13.Google Scholar
  35. 35.
    Infection Group, Branch of Respiration of Chinese Medical Society & Editorial Committee of Chinese Journal of Tuberculosis and Respiration. Consensus on diagnosis and treatment of pulmonary mycosis. Chin J Tuberc Respir. 2007;30(11):821–34.Google Scholar
  36. 36.
    Pappas PG, Kauffman C, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(5):503–35.PubMedCrossRefGoogle Scholar
  37. 37.
    Lee JK, Lee YJ, Park SS, et al. Clinical course and prognostic factors of pulmonary aspergilloma. Respirology. 2014;19(7):1066–72.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Sharma S, Dubey SK, Kumar N, et al. Monod and air crescent sign in aspergilloma. BMJ Case Rep. 2013;  https://doi.org/10.1136/bcr-2013-200936.Google Scholar
  39. 39.
    Moodley L, Pillay J, Dheda K. Aspergilloma and the surgeon. J Thorac Dis. 2014;6(3):202–9.PubMedPubMedCentralGoogle Scholar
  40. 40.
    Fernández-Ruiz M, Silva JT, San-Juan R, et al. Aspergillus tracheobronchitis: report of 8 cases and review of the literature. Balt For. 2012;91(5):261–73.CrossRefGoogle Scholar
  41. 41.
    Greene RE, Sehlamra lT, Oestmaun JW. CT imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis. 2007;44(3):373–9.PubMedCrossRefGoogle Scholar
  42. 42.
    Tasci S, Glasmacher A, Lentini S, et al. Pseudomembranous and obstructive aspergillus tracheobronchitis: optimal diagnostic strategy and outcome. Mycoses. 2006;49(1):37–42.PubMedCrossRefGoogle Scholar
  43. 43.
    Danner BC. Surgical treatment of pulmonary aspergillosis/mycosis in immunocompromised patients. Interact Cardiovasc Thorac Surg. 2008;7(5):771–6.PubMedCrossRefGoogle Scholar
  44. 44.
    Patterson KC, Strek ME. Diagnosis and treatment of pulmonary aspergillosis syndromes. J Chest. 2014;146(5):1358–68.CrossRefGoogle Scholar
  45. 45.
    Park SY, Lee SO, Choi SH, et al. Serum and bronchoalveolar lavage fluid galactomannan assays in patients with pulmonary aspergilloma. Clin Infect Dis. 2011;52(7):e149–52.PubMedPubMedCentralCrossRefGoogle Scholar
  46. 46.
    Zou M, Tang L, Zhao S, et al. Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis. PLoS One. 2012;7(8):e43347.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Limper AH, Knox KS, Sarosi CA, et al. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med. 2011;183(1):196–28.CrossRefGoogle Scholar
  48. 48.
    Liu Y, She D, Sun T, et al. Multi-centered retrospective survey of clinically definitive cases of pulmonary mycosis during 1998 to 2007 in China. Chin J Tuberc Respir. 2011;34(2):85–90.Google Scholar
  49. 49.
    Zhang Z, Chen B. Clinical data analysis of pulmonary aspergillosis in the past 20 years in China. Int J Respir. 2009;29(4):193–6.Google Scholar
  50. 50.
    Smith NL, Denning DW. Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma. Eur Respir J. 2011;37:865–72.PubMedCrossRefGoogle Scholar
  51. 51.
    Sonnenberg P, Murray J, Glynn JR, et al. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet. 2001;358:1687–93.PubMedCrossRefGoogle Scholar
  52. 52.
    Hamilton CD, Stout JE, Goodman PC, et al. The value of end-of-treatment chest radiograph in predicting pulmonary tuberculosis relapse. Int J Tuberc Lung Dis. 2008;12:1059–64.PubMedPubMedCentralGoogle Scholar
  53. 53.
    Mohapatra B, Sivakumar P, Bhattacharya S, et al. Aspergilloma and residual tuberculous cavities—the results of a resurvey. Tubercle. 1970;51:227–45.CrossRefGoogle Scholar
  54. 54.
    British Tuberculosis Association. Aspergillus in persistent lung cavities after tuberculosis. A report from the Research Committee of the British Tuberculosis Association. Tubercle. 1968;49:1–11.CrossRefGoogle Scholar
  55. 55.
    Li X, Xie H, Li S. Clinical typing and radiological demonstrations of pulmonary aspergillosis. Chin J Med Comput Imaging. 2010;16(5):384–8.Google Scholar
  56. 56.
    Thomas JW, Elias JA, David WD, et al. Aspergillus. Clin Infect Dis. 2008;46:327–60.CrossRefGoogle Scholar
  57. 57.
    Li Y. CT scan demonstrations of pulmonary tuberculosis complicated by aspergillus infection. J Mod Diagn Treat. 2015;26(1):157–8.Google Scholar
  58. 58.
    Denning DW, Pleuvry A, Cole DC. Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis. Bull WHO. 2011;89(12):864–72.PubMedGoogle Scholar
  59. 59.
    Agarwal AK, Bhagat R, Panchal N, et al. Allergic bronchopulmonary aspergillosis with aspergilloma mimicking fibrocavitary pulmonary tuberculosis. Asian Pac J Allergy Immunol. 1996;14(1):5–8.PubMedGoogle Scholar
  60. 60.
    Yoon SH, Park CM, Goo JM, et al. Pulmonary aspergillosis in immunocompetent patients without air-meniscus sign and underlying lung disease: CT findings and histopathologic features. J Acta Radiol. 2011;52:756–61.CrossRefGoogle Scholar
  61. 61.
    Chien WL, Tseng JS. Pulmonary aspergillosis in an immunocompetent patient. Braz J Infect Dis. 2013;17:375–6.PubMedCrossRefGoogle Scholar
  62. 62.
    Martinez D, Ananda-Rajah MR, Suominen H, et al. Automatic detection of patients with invasive fungal disease from free-text computed tomography (CT) scans. J Biomed Inform. 2015;53:251–60.PubMedCrossRefGoogle Scholar
  63. 63.
    Oliva A, Flori P, Hennequin C, et al. Evaluation of the Aspergillus Western blot IgG kit for diagnosis of chronic aspergillosis. J Clin Microbiol. 2015;53(1):248–54.PubMedCrossRefGoogle Scholar
  64. 64.
    Thomas JW, Elias JA. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46(3):327–60.CrossRefGoogle Scholar
  65. 65.
    Chun J-Y, Morgan R, Belli A-M. Radiological management of hemoptysis: a comprehensive review of diagnostic imaging and bronchial arterial embolization. Eur Radiol. 2010;33(2):240–50.Google Scholar
  66. 66.
    Lee YR, Choi YW, Lee KJ, et al. CT halo sign: the spectrum of pulmonary diseases. Br J Radiol. 2005;78(933):862–5.PubMedCrossRefGoogle Scholar
  67. 67.
    Jeannette G, Mary EB. Histopathologic Diagnosis of Fungal Infections in the 21st Century. Am Soc Microbiol. 2011;24(2):247–80.Google Scholar
  68. 68.
    Farid S, Mohamed S, Devbhandari M, et al. Results of surgery for chronic pulmonary aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence—a National Centre’s experience. J Cardiothorac Surg. 2013;8(1):180.PubMedPubMedCentralCrossRefGoogle Scholar
  69. 69.
    Sagan D, Goździuk K, Korobowicz E. Predictive and prognostic value of preoperative symptoms in the surgical treatment of pulmonary aspergilloma. J Surg Res. 2010;163(2):35–43.CrossRefGoogle Scholar
  70. 70.
    Zhang J, Qu J. Disease spectrum of pulmonary aspergillosis and the strategies for their diagnosis. Chin J Tuberc Respir. 2015;38(1):11–3.Google Scholar
  71. 71.
    Editorial Committee of Chinese Journal of Internal Medicine. Diagnostic criteria and therapeutic principles of invasive pulmonary fungal infection. Chin J Intern Med. 2006;45(8):697–700.Google Scholar
  72. 72.
    Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J. 2007;30(4):782–800.PubMedCrossRefGoogle Scholar
  73. 73.
    Guinea J, Torres-Narbona M, Gijón P, et al. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect. 2010;16:870–7.PubMedCrossRefGoogle Scholar
  74. 74.
    Leeflang MM, Debets-Ossenkopp YJ, Visser CE, et al. Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane Database Syst Rev. 2008;(4):CD007394.Google Scholar
  75. 75.
    Park SY, Lee SO, Choi SH. Serum and bronchoalveolar lavage fluid galactomannan assay in patients with pulmonary aspergilloma. Clin Infect Dis. 2011;52:e149–52.PubMedPubMedCentralCrossRefGoogle Scholar
  76. 76.
    Shroff S, Shorrf GS, Yust-katz S, et al. The CT halo sign in invasive aspergillosis. J Clin Case Rep. 2014;2(3):113–4.CrossRefGoogle Scholar
  77. 77.
    Luo BL, Zhang LM, Hu CP, et al. Clinical analysis of 68 patients with pulmonary mycosis in China. Multidiscip Respir Med. 2011;6(5):278–83.PubMedPubMedCentralCrossRefGoogle Scholar
  78. 78.
    Singh Sehgal I, Agarwal R. Pulse methylprednisolone in allergic bronchopulmonary aspergillosis exacerbations. J Eur Respir Rev. 2014;23(131):149–52.CrossRefGoogle Scholar
  79. 79.
    Bozeman S, deShazo R, Stringer S, et al. Complications of allergic fungal sinusitis. Am J Med. 2011;124:359–68.PubMedCrossRefGoogle Scholar
  80. 80.
    Thompson GR 3rd, Patterson TF. Fungal disease of the nose and paranasal sinuses. J Allergy Clin Immunol. 2012;129:321–6.PubMedCrossRefGoogle Scholar
  81. 81.
    Tsabouri S, Tseretopoulou X, Priftis K, et al. Omalizumab for the treatment of inadequately controlled allergic rhinitis: a systematic review and meta-analysis of randomized clinical trials. J Allergy Clin Immunol Pract. 2014;2:332–40.PubMedCrossRefGoogle Scholar
  82. 82.
    Moreira AS, Silva D, Ferreira AR, et al. Antifungal treatment in allergic bronchopulmonary aspergillosis with and without cystic fibrosis: a systematic review. Clin Exp Allergy. 2014;44:1210–27.PubMedCrossRefGoogle Scholar
  83. 83.
    Howard BE, Lal D. Oral steroid therapy in chronic rhinosinusitis with and without nasal polyposis. Curr Allergy Asthma Rep. 2013;13:236–43.PubMedCrossRefGoogle Scholar
  84. 84.
    Tanou K, Zintzaras E, Kaditis AG. Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence. Pediatr Pulmonol. 2014;49:503–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. and Peoples Medical Publishing House, PR of China 2019

Authors and Affiliations

  • Shi-Ping Wu
    • 1
  • Ling-Wei Wang
    • 1
  1. 1.Second Clinical Medical College of Jinan UniversityShenzhenChina

Personalised recommendations